The Inspire Implant, hypoglossal nerve stimulation, was FDA approved in 2014 for the treatment of moderate to severe obstructive sleep apnea for patients unable to tolerate treatment with CPAP. The implant was placed utilizing three incisions, one below the jaw for placement of the nerve stimulator, one in between the ribs for placement of the respiratory sensor, and one in the upper chest for placement of the generator.
The surgical technique has recently been modified, so that only two incisions are now necessary. The incision in between the ribs has been eliminated, and the respiratory sensory in now placed through the upper chest incision, alongside the generator. The advantages of the two incision approach include shorter operating time, reduced post-operative pain, and reduced risk of infection. The procedure is performed on an outpatient basis, with patients returning home the same day. The device is activated four weeks following implant placement.
The Inspire Implant has a high success and patient satisfaction rate for those with moderate to severe obstructive sleep apnea who are unable to tolerate treatment with CPAP.